Application of One-handed Lithotripsy in Percutaneous Nephrolithotomy

Launched by THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA · Dec 13, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new technique for a surgical procedure called percutaneous nephrolithotomy (PCNL), which is used to remove kidney stones located in the upper urinary tract. Traditionally, this procedure requires both hands to operate the tools, but this trial is exploring the use of a one-handed approach. The researchers want to see if this method is safe and effective, making the procedure easier for surgeons to perform.

To be eligible for this trial, participants should be between 65 and 74 years old and have been recommended for PCNL surgery according to recent guidelines. They must also agree to try the one-handed technique. However, individuals with certain health issues, such as serious heart or lung problems, or those with specific types of kidney stones that could complicate the surgery, cannot participate. If you join this study, you can expect to undergo this innovative procedure and contribute to important research that could help improve kidney stone treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Disease.
• • Participants who agree to undergo one-hand lithotripsy.
• Exclusion Criteria:
• • Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function.
• • Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones

Trial Officials